Clinomic Group GmbH
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Clinomic Group GmbH - overview
Established
2019
Location
Aachen, -, Germany
Primary Industry
Medical Devices & Equipment
About
Based in Aachen, Germany, and founded in 2019, Clinomic Group GmbH provides artificial intelligence-based as well as resource-driven digital transformation to the healthcare industry. The company was founded by Dr. medical Luke Martin and Dr. medical Arne Peine.
In July 2023, Clinomic Group GmbH raised EUR 16 million in venture funding from new investor Sana Kliniken AG, with participation from other unspecified investors. The company offers an artificial intelligence-based device named Mona which is a smart bedside device for the intensive care unit and provides assistance in the treatment of patients. Additionally, the firm provides a telemedicine center where critical care doctors and nurses are available 24/7 with the on-site hospital team. Furthermore, the company provides clinical data solutions which include clinical data mining platforms and a clinomic data lake that helps in big data visualization as well as in decision making.
The company plans to use the July 2023 funding to support the development of its product and growth.
Current Investors
Sana Kliniken AG, Bolero Holdings, KG Investment GmbH
Primary Industry
Medical Devices & Equipment
Sub Industries
Medical Devices & Equipment, Medical Software
Website
www.clinomic.ai
Verticals
Artificial Intelligence, HealthTech, Manufacturing
Company Stage
Series B
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.